These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15584921)

  • 1. Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone.
    Böttcher T; Ren H; Goiny M; Gerber J; Lykkesfeldt J; Kuhnt U; Lotz M; Bunkowski S; Werner C; Schau I; Spreer A; Christen S; Nau R
    J Neurochem; 2004 Dec; 91(6):1450-60. PubMed ID: 15584921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.
    Spreer A; Lugert R; Stoltefaut V; Hoecht A; Eiffert H; Nau R
    Crit Care Med; 2009 Jul; 37(7):2253-8. PubMed ID: 19487938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis.
    Böttcher T; Gerber J; Wellmer A; Smirnov AV; Fakhrjanali F; Mix E; Pilz J; Zettl UK; Nau R
    J Infect Dis; 2000 Jun; 181(6):2095-8. PubMed ID: 10837202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
    Trostdorf F; Reinert RR; Schmidt H; Nichterlein T; Stuertz K; Schmitz-Salue M; Sadowski I; Brück W; Nau R
    J Antimicrob Chemother; 1999 Jan; 43(1):87-94. PubMed ID: 10381105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone.
    Gerber J; Pohl K; Sander V; Bunkowski S; Nau R
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1313-7. PubMed ID: 12654664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.
    Spreer A; Kerstan H; Böttcher T; Gerber J; Siemer A; Zysk G; Mitchell TJ; Eiffert H; Nau R
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2649-54. PubMed ID: 12878534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal treatment with the anti-phosphorylcholine monoclonal antibody TEPC-15 decreases neuronal damage in experimental pneumococcal meningitis.
    Gerber J; Redlich S; Ribes S; Tauber SC; Schmidt H; Nau R
    Chemotherapy; 2012; 58(3):212-6. PubMed ID: 22759864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis.
    Nau R; Wellmer A; Soto A; Koch K; Schneider O; Schmidt H; Gerber J; Michel U; Brück W
    J Infect Dis; 1999 Jun; 179(6):1557-60. PubMed ID: 10228082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
    Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.
    Stuertz K; Schmidt H; Trostdorf F; Eiffert H; Mäder M; Nau R
    Scand J Infect Dis; 1999; 31(4):367-70. PubMed ID: 10528875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin is neuroprotective in experimental Streptococcus pneumoniae meningitis.
    Gerber J; Lotz M; Ebert S; Kiel S; Huether G; Kuhnt U; Nau R
    J Infect Dis; 2005 Mar; 191(5):783-90. PubMed ID: 15688296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of capsular and clonal types and beta-lactam resistance to the severity of experimental pneumococcal meningitis.
    Ribes S; Taberner F; Cabellos C; Tubau F; Ardanuy C; Gerber J; Liñares J; Nau R; Gudiol F
    Microbes Infect; 2008 Feb; 10(2):129-34. PubMed ID: 18248756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of NF-kappaB1 (p50) in experimental pneumococcal meningitis.
    Kastenbauer S; Koedel U; Weih F; Ziegler-Heitbrock L; Pfister HW
    Eur J Pharmacol; 2004 Sep; 498(1-3):315-8. PubMed ID: 15364010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
    Grandgirard D; Schürch C; Cottagnoud P; Leib SL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice.
    Herrmann I; Kellert M; Spreer A; Gerber J; Eiffert H; Prinz M; Nau R
    J Antimicrob Chemother; 2007 Jan; 59(1):74-9. PubMed ID: 17079237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.